166 related articles for article (PubMed ID: 37798206)
21. Feasibility of artificial intelligence-based decision supporting system in tolvaptan prescription for autosomal dominant polycystic kidney disease.
Shin JH; Kim YH; Lee MK; Min HS; Cho H; Kim H; Kim YC; Lee YS; Shin TY
Investig Clin Urol; 2023 May; 64(3):255-264. PubMed ID: 37341005
[TBL] [Abstract][Full Text] [Related]
22. Kidney and cystic volume imaging for disease presentation and progression in the cat autosomal dominant polycystic kidney disease large animal model.
Yu Y; Shumway KL; Matheson JS; Edwards ME; Kline TL; Lyons LA
BMC Nephrol; 2019 Jul; 20(1):259. PubMed ID: 31299928
[TBL] [Abstract][Full Text] [Related]
23. Automatic semantic segmentation of kidney cysts in MR images of patients affected by autosomal-dominant polycystic kidney disease.
Kline TL; Edwards ME; Fetzer J; Gregory AV; Anaam D; Metzger AJ; Erickson BJ
Abdom Radiol (NY); 2021 Mar; 46(3):1053-1061. PubMed ID: 32940759
[TBL] [Abstract][Full Text] [Related]
24. Autosomal dominant polycystic kidney disease: new role for ultrasound.
İmamoğlu H; Zararsız G; Doğan S; Koçyiğit İ; Eroğlu E; Öztürk A; Erdoğan N
Eur Radiol; 2019 Nov; 29(11):5991-5998. PubMed ID: 31028448
[TBL] [Abstract][Full Text] [Related]
25. Hemorrhagic Cysts and Other MR Biomarkers for Predicting Renal Dysfunction Progression in Autosomal Dominant Polycystic Kidney Disease.
Riyahi S; Dev H; Blumenfeld JD; Rennert H; Yin X; Attari H; Barash I; Chicos I; Bobb W; Donahue S; Prince MR
J Magn Reson Imaging; 2021 Feb; 53(2):564-576. PubMed ID: 32969110
[TBL] [Abstract][Full Text] [Related]
26. Reliability of Total Renal Volume Computation in Polycystic Kidney Disease From Magnetic Resonance Imaging.
Turco D; Severi S; Mignani R; Aiello V; Magistroni R; Corsi C
Acad Radiol; 2015 Nov; 22(11):1376-84. PubMed ID: 26276168
[TBL] [Abstract][Full Text] [Related]
27. Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP).
O'Neill WC; Robbin ML; Bae KT; Grantham JJ; Chapman AB; Guay-Woodford LM; Torres VE; King BF; Wetzel LH; Thompson PA; Miller JP
Am J Kidney Dis; 2005 Dec; 46(6):1058-64. PubMed ID: 16310571
[TBL] [Abstract][Full Text] [Related]
28. Automatic total kidney volume measurement on follow-up magnetic resonance images to facilitate monitoring of autosomal dominant polycystic kidney disease progression.
Kline TL; Korfiatis P; Edwards ME; Warner JD; Irazabal MV; King BF; Torres VE; Erickson BJ
Nephrol Dial Transplant; 2016 Feb; 31(2):241-8. PubMed ID: 26330562
[TBL] [Abstract][Full Text] [Related]
29. Improved predictions of total kidney volume growth rate in ADPKD using two-parameter least squares fitting.
Hu Z; Sharbatdaran A; He X; Zhu C; Blumenfeld JD; Rennert H; Zhang Z; Ramnauth A; Shimonov D; Chevalier JM; Prince MR
Sci Rep; 2024 Jun; 14(1):13794. PubMed ID: 38877066
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Total Kidney Volume Quantification Methods in Autosomal Dominant Polycystic Disease for a Comprehensive Disease Assessment.
Turco D; Busutti M; Mignani R; Magistroni R; Corsi C
Am J Nephrol; 2017; 45(5):373-379. PubMed ID: 28315882
[TBL] [Abstract][Full Text] [Related]
31. Magnetic Resonance Kidney Parenchyma-T2 as a Novel Imaging Biomarker for Autosomal Dominant Polycystic Kidney Disease.
Siedek F; Grundmann F; Weiss K; Pinto Dos Santos D; Arjune S; Haneder S; Persigehl T; Müller RU; Baessler B
Invest Radiol; 2020 Apr; 55(4):217-225. PubMed ID: 31876626
[TBL] [Abstract][Full Text] [Related]
32. Novel three-dimensional imaging volumetry in autosomal dominant polycystic kidney disease: comparison with 2D volumetry.
Shin D; Lee KB; Hyun YY; Lee YR; Hwang YH; Park HC; Ahn C
Clin Nephrol; 2014 Aug; 82(2):98-106. PubMed ID: 25029513
[TBL] [Abstract][Full Text] [Related]
33. 3DUS as an alternative to MRI for measuring renal volume in children with autosomal dominant polycystic kidney disease.
Breysem L; De Rechter S; De Keyzer F; Smet MH; Bammens B; Van Dyck M; Hofmans M; Oyen R; Levtchenko E; Mekahli D
Pediatr Nephrol; 2018 May; 33(5):827-835. PubMed ID: 29306987
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Performance of Kidney Volume Measurement for Polycystic Kidney Disease: A Comparative Study of Ellipsoid vs. Manual Segmentation.
Shi B; Akbari P; Pourafkari M; Iliuta IA; Guiard E; Quist CF; Song X; Hillier D; Khalili K; Pei Y
Sci Rep; 2019 Jul; 9(1):10996. PubMed ID: 31358787
[TBL] [Abstract][Full Text] [Related]
35. CT of Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: Accuracy, Reproducibility, and Radiation Dose.
Bevilacqua MU; Hague CJ; Romann A; Sheitt H; Vasilescu DM; Yi TW; Levin A
Radiology; 2019 Jun; 291(3):660-667. PubMed ID: 30964424
[TBL] [Abstract][Full Text] [Related]
36. Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease.
Kline TL; Korfiatis P; Edwards ME; Bae KT; Yu A; Chapman AB; Mrug M; Grantham JJ; Landsittel D; Bennett WM; King BF; Harris PC; Torres VE; Erickson BJ;
Kidney Int; 2017 Nov; 92(5):1206-1216. PubMed ID: 28532709
[TBL] [Abstract][Full Text] [Related]
37. The Association of Combined Total Kidney and Liver Volume with Pain and Gastrointestinal Symptoms in Patients with Later Stage Autosomal Dominant Polycystic Kidney Disease.
D'Agnolo HMA; Casteleijn NF; Gevers TJG; de Fijter H; van Gastel MDA; Messchendorp AL; Peters DJM; Salih M; Soonawala D; Spithoven EM; Visser FW; Wetzels JFM; Zietse R; Gansevoort RT; Drenth JPH
Am J Nephrol; 2017; 46(3):239-248. PubMed ID: 28881341
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderly.
Marizzoni M; Antelmi L; Bosch B; Bartrés-Faz D; Müller BW; Wiltfang J; Fiedler U; Roccatagliata L; Picco A; Nobili F; Blin O; Bombois S; Lopes R; Sein J; Ranjeva JP; Didic M; Gros-Dagnac H; Payoux P; Zoccatelli G; Alessandrini F; Beltramello A; Bargalló N; Ferretti A; Caulo M; Aiello M; Cavaliere C; Soricelli A; Salvadori N; Parnetti L; Tarducci R; Floridi P; Tsolaki M; Constantinidis M; Drevelegas A; Rossini PM; Marra C; Hoffmann KT; Hensch T; Schönknecht P; Kuijer JP; Visser PJ; Barkhof F; Bordet R; Frisoni GB; Jovicich J;
Hum Brain Mapp; 2015 Sep; 36(9):3516-27. PubMed ID: 26043939
[TBL] [Abstract][Full Text] [Related]
39. Volume regression of native polycystic kidneys after renal transplantation.
Jung Y; Irazabal MV; Chebib FT; Harris PC; Dean PG; Prieto M; Cosio FG; El-Zoghby ZM; Torres VE
Nephrol Dial Transplant; 2016 Jan; 31(1):73-9. PubMed ID: 26044834
[TBL] [Abstract][Full Text] [Related]
40. Intraobserver and interobserver variability of renal volume measurements in polycystic kidney disease using a semiautomated MR segmentation algorithm.
Cohen BA; Barash I; Kim DC; Sanger MD; Babb JS; Chandarana H
AJR Am J Roentgenol; 2012 Aug; 199(2):387-93. PubMed ID: 22826401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
